Sublime
An inspiration engine for ideas
Everyone connected in any way to the biotech and pharma world should watch this.
Adam Feuerstein ✡️x.comHIV protection with just two shots a year: FDA approves Gilead $GILD drug https://t.co/3CCSJC9ZO4... See more
Adam Feuerstein ✡️x.com
NEW ARTICLE: Pfizer completes $43 Billion acquisition of Seagen on Dec.14, 2023 - becomes largest oncology company to treat most TURBO CANCERS caused by mRNA Vaccines - deep dive into the sinister aspects of this very bizarre deal.
Pfizer OVERPAYS $43 billion on small Cancer Drug Company that barely makes $2 billion a y... See more
For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug
GLP1s have added $1T in market cap to Eli and Novo over the last 5 years. That's 3x+ the market cap created by all biopharma startups over the last 30 years combined. This is a bit of an indicment of the biotech startup ecosystem. There are many $1T and even $10T drugs to be invented, we just don't fund them. Through no one persons fault, the biote... See more
Blake Byersx.com
Why Is Healthcare the Hottest Sector in the Market Right Now
AI is no longer creeping into healthcare -- it’s bulldozing through it, forcing a fundamental reset of how medicine is developed, delivered, and monetized. Investors are no longer speculating; they’re reallocating capital toward the companies driving this shif... See more
Solving "boring" problems can be lucrative in life science. Danaher is a conglomerate that makes your centrifuges, antibodies, microscopes, etc. Within ~1/2x $AAPL return since '85...without making a drug. "Hard" to replicate but underrated in all the high-flying tech talk. https://t.co/2zVGmHeFkf
